You just read:

Bausch + Lomb Announces The U.S. Launch Of LOTEMAX® SM (Loteprednol Etabonate Ophthalmic Gel) 0.38% For The Treatment Of Postoperative Inflammation And Pain Following Ocular Surgery

News provided by

Bausch Health Companies Inc.

Apr 02, 2019, 07:00 ET